-
1
NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
Published 2023-11-01Get full text
Article -
2
Neuronal loss drives differentially expressed protein‐pathways in the PSP globus pallidus
Published 2023-07-01Get full text
Article -
3
Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
Published 2020-04-01Get full text
Article -
4
-
5
-
6
-
7
-
8
-
9
Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson’s disease
Published 2023-02-01Get full text
Article -
10
-
11
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Published 2019-04-01Get full text
Article -
12
-
13
Disease‐specific phenotypes in iPSC‐derived neural stem cells with POLG mutations
Published 2020-10-01Get full text
Article -
14
-
15
-
16
Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
Published 2023-06-01Get full text
Article -
17
Not every estimate counts – evaluation of cell composition estimation approaches in brain bulk tissue data
Published 2023-06-01Get full text
Article -
18
-
19
Mitochondrial Respiratory Chain Dysfunction—A Hallmark Pathology of Idiopathic Parkinson’s Disease?
Published 2022-04-01Get full text
Article -
20
Editorial: Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond
Published 2022-05-01Get full text
Article